EE03684B1 - Antimükootilist aktiivsust omavad asoolühendid kasutamiseks meditsiinis ja veterinaarias - Google Patents

Antimükootilist aktiivsust omavad asoolühendid kasutamiseks meditsiinis ja veterinaarias

Info

Publication number
EE03684B1
EE03684B1 EE9800261A EE9800261A EE03684B1 EE 03684 B1 EE03684 B1 EE 03684B1 EE 9800261 A EE9800261 A EE 9800261A EE 9800261 A EE9800261 A EE 9800261A EE 03684 B1 EE03684 B1 EE 03684B1
Authority
EE
Estonia
Prior art keywords
medical
veterinary use
azole compounds
antimycotic activity
antimycotic
Prior art date
Application number
EE9800261A
Other languages
English (en)
Estonian (et)
Other versions
EE9800261A (et
Inventor
Napoletano Mauro
Fraire Cristina
Albini Enrico
Schioppacassi Giovanna
Original Assignee
Zambon Group S.P.A.
Isagro S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zambon Group S.P.A., Isagro S.P.A. filed Critical Zambon Group S.P.A.
Publication of EE9800261A publication Critical patent/EE9800261A/xx
Publication of EE03684B1 publication Critical patent/EE03684B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C07D233/60—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms with hydrocarbon radicals, substituted by oxygen or sulfur atoms, attached to ring nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Devices For Medical Bathing And Washing (AREA)
EE9800261A 1996-02-28 1997-02-25 Antimükootilist aktiivsust omavad asoolühendid kasutamiseks meditsiinis ja veterinaarias EE03684B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT96MI000371A IT1283038B1 (it) 1996-02-28 1996-02-28 Composti azolici ad attivita' antimicotica per uso umano e veterinario
PCT/EP1997/000886 WO1997031903A1 (en) 1996-02-28 1997-02-25 Azole compounds endowed with antimycotic activity for human and veterinary use

Publications (2)

Publication Number Publication Date
EE9800261A EE9800261A (et) 1999-02-15
EE03684B1 true EE03684B1 (et) 2002-04-15

Family

ID=11373418

Family Applications (1)

Application Number Title Priority Date Filing Date
EE9800261A EE03684B1 (et) 1996-02-28 1997-02-25 Antimükootilist aktiivsust omavad asoolühendid kasutamiseks meditsiinis ja veterinaarias

Country Status (32)

Country Link
US (2) US5869512A (zh)
EP (1) EP0877739B1 (zh)
JP (1) JP2000505466A (zh)
KR (1) KR19990087363A (zh)
CN (1) CN1082050C (zh)
AP (1) AP9801328A0 (zh)
AT (1) ATE219066T1 (zh)
AU (1) AU713049B2 (zh)
BG (1) BG102711A (zh)
BR (1) BR9707773A (zh)
CA (1) CA2247390A1 (zh)
CZ (1) CZ291790B6 (zh)
DE (1) DE69713276T2 (zh)
DK (1) DK0877739T3 (zh)
EA (1) EA003189B1 (zh)
EE (1) EE03684B1 (zh)
ES (1) ES2176689T3 (zh)
GE (1) GEP20002091B (zh)
HU (1) HUP9900569A3 (zh)
IL (1) IL125701A (zh)
IT (1) IT1283038B1 (zh)
NO (1) NO983953L (zh)
NZ (1) NZ331919A (zh)
OA (1) OA10847A (zh)
PL (1) PL328582A1 (zh)
PT (1) PT877739E (zh)
SI (1) SI0877739T1 (zh)
SK (1) SK283391B6 (zh)
TR (1) TR199801688T2 (zh)
UA (1) UA55405C2 (zh)
WO (1) WO1997031903A1 (zh)
ZA (1) ZA971665B (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1296925B1 (it) 1997-12-05 1999-08-03 Zambon Spa Procedimento per la preparazione di composti ad attivita' antimicotica
US6297115B1 (en) * 1998-11-06 2001-10-02 Advanced Micro Devices, Inc. Cmos processs with low thermal budget
AU2003211498A1 (en) 2002-02-15 2003-09-04 Mitsui Chemicals, Inc. Optically active azole derivative and process for producing the same
GB0222964D0 (en) 2002-10-03 2002-11-13 Unilever Plc Polymeric film for water soluble package

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU187399B (en) * 1980-12-24 1985-12-28 Sumitomo Chemical Co Process for preparing imidazolyl-propanol derivatives
EP0061835B1 (en) * 1981-03-18 1989-02-01 Imperial Chemical Industries Plc Triazole compounds, a process for preparing them, their use as plant fungicides and fungicidal compositions containing them
DE3271901D1 (en) * 1982-02-03 1986-08-07 Ici Plc Heterocyclic compounds useful as pesticides and processes for making them
US4505919A (en) * 1982-10-09 1985-03-19 Pfizer Inc. Antifungal S-arylmethyl- and S-heterocyclylmethyl ethers of 2-aryl-3-mercapto-1-(1H-1,2,4-triazol-1-yl) propan-2-ols
AU572889B2 (en) * 1983-09-26 1988-05-19 Sumitomo Chemical Company, Limited 1,2,4 - triazolyl propanols
KR930004193B1 (ko) * 1984-10-02 1993-05-21 스미또모 세이야꾸 가부시끼가이샤 N-치환된 트리아졸 유도체의 제조방법
US5081138A (en) * 1986-12-17 1992-01-14 Merck Frosst Canada, Inc. 3-hetero-substituted-n-benzyl-indoles and prevention of leucotriene synthesis therewith
IT1198240B (it) * 1986-12-23 1988-12-21 Agrimont Spa Azolilderivati fungicidi
IT1232943B (it) * 1987-11-09 1992-03-10 Mini Ricerca Scient Tecnolog Azolilderivati fungicidi.
US5134152A (en) * 1989-12-07 1992-07-28 Sankyo Company, Limited Oxetane derivatives and their use as anti-fungal or fungicidal agents
CA2031892C (en) * 1989-12-25 2000-08-01 Minoru Tokizawa Triazole derivatives
CA2049802A1 (en) * 1990-08-26 1992-02-27 Sadao Oida Anti-fungal triazole derivatives, their preparation and uses
GB9307924D0 (en) * 1993-04-16 1993-06-02 Zeneca Ltd Chrial synthesis
CA2145458A1 (en) * 1994-03-28 1995-09-29 Hiroki Kodama Triazole compound and production process and use thereof
IT1273509B (it) * 1995-04-07 1997-07-08 Zambon Spa Composti azolici ad attivita' antimicotica per uso umano e veterinario

Also Published As

Publication number Publication date
OA10847A (en) 2003-02-05
AU713049B2 (en) 1999-11-25
HUP9900569A1 (hu) 1999-06-28
EP0877739B1 (en) 2002-06-12
ES2176689T3 (es) 2002-12-01
SK116198A3 (en) 1999-02-11
IL125701A (en) 2003-11-23
HUP9900569A3 (en) 2001-07-30
EA199800693A1 (ru) 1999-06-24
DE69713276D1 (de) 2002-07-18
CZ274898A3 (cs) 1999-01-13
UA55405C2 (uk) 2003-04-15
EE9800261A (et) 1999-02-15
CN1082050C (zh) 2002-04-03
DK0877739T3 (da) 2002-10-07
NO983953D0 (no) 1998-08-27
PT877739E (pt) 2002-11-29
KR19990087363A (ko) 1999-12-27
ATE219066T1 (de) 2002-06-15
AU2092997A (en) 1997-09-16
EP0877739A1 (en) 1998-11-18
NZ331919A (en) 1999-04-29
DE69713276T2 (de) 2003-03-06
EA003189B1 (ru) 2003-02-27
ZA971665B (en) 1997-08-29
IL125701A0 (en) 1999-04-11
US5869512A (en) 1999-02-09
PL328582A1 (en) 1999-02-01
WO1997031903A1 (en) 1997-09-04
ITMI960371A1 (it) 1997-08-28
JP2000505466A (ja) 2000-05-09
CN1212685A (zh) 1999-03-31
CZ291790B6 (cs) 2003-05-14
ITMI960371A0 (zh) 1996-02-28
BR9707773A (pt) 2000-01-04
IT1283038B1 (it) 1998-04-07
SI0877739T1 (en) 2002-12-31
BG102711A (bg) 1999-04-30
GEP20002091B (en) 2000-05-10
US6103909A (en) 2000-08-15
AP9801328A0 (en) 1998-09-30
NO983953L (no) 1998-10-26
SK283391B6 (sk) 2003-07-01
TR199801688T2 (xx) 1998-11-23
CA2247390A1 (en) 1997-09-04

Similar Documents

Publication Publication Date Title
FI955051A0 (fi) Heterosyklisiä yhdisteitä ja niiden valmistus ja käyttö
NO980006D0 (no) Slange for medisinsk bruk
DE69506901D1 (de) Körperpflegemittel
BR9708882A (pt) Triazolil mercaptidas e sua ulitização como microbicidas
NO973321D0 (no) Sårhakesystem for anvendelse av kirurgiske operasjoner
NO980007L (no) Fremgangsmåte for ekstrudering av slanger for medisinsk bruk
NO980008L (no) Fremgangsmåte for ekstrudering av slanger for medisinsk bruk
EE9900524A (et) N-triasolüül-2-indoolkarboksamiidid ja nende kasutamine CCK-A agonistidena
EE9800261A (et) Antimükootilist aktiivsust omavad asoolühendid kasutamiseks meditsiinis ja veterinaarias
NO991458D0 (no) Antimykotisk gel med h°y virkestoff-frigivelse
DK0819124T3 (da) Azolforbindelser med antimykotisk aktivitet til human og veterinær anvendelse
KR950022790U (ko) 의료용 침구
KR960007082U (ko) 치 의료용 냉각수 분사기
BR9602210A (pt) Ambuláncia veterinária
ITMI960235A1 (it) Composti azolici ad attivita' antimicotica per uso umano e veterinario
ITRE940074A0 (it) Attrezzo per la movimentazione rapida ed incruenta del bestiame, particolarmente per suini
KR960000467U (ko) 일회용 의료 응급처치 세트
FR2719484B1 (fr) Ventilateur à usage médical.
BR9603425A (pt) Protetor descartável para seiringa tríplice
KR960020183U (ko) 의료용 멸균기
CY2012008I1 (el) 8α-αζαλιδες ως κτηνιατρικα αντιμικροβιακα μεσα
KR970056915U (ko) 의료침대용 핸들
IT1284068B1 (it) Composti dotati di attivita' antibiotica e antimicotica
BR7700977U (pt) Disposição aplicada em cadeira para trabalho médico

Legal Events

Date Code Title Description
KB4A Valid patent at the end of a year

Effective date: 20021231

KB4A Valid patent at the end of a year

Effective date: 20031231

MM4A Lapsed by not paying the annual fees

Effective date: 20040225